Found: 8
Select item for more details and to access through your institution.
Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimod.
- Published in:
- Frontiers in Drug Delivery, 2024, p. 1, doi. 10.3389/fddev.2024.1425144
- By:
- Publication type:
- Article
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267866
- By:
- Publication type:
- Article
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1238861
- By:
- Publication type:
- Article
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00530-9
- By:
- Publication type:
- Article
Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4362, doi. 10.3390/ijms23084362
- By:
- Publication type:
- Article
The Anti-apoptotic Murine Cytomegalovirus Protein vMIA-m38.5 Induces Mast Cell Degranulation.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. N.PAG, doi. 10.3389/fcimb.2020.00439
- By:
- Publication type:
- Article
Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice.
- Published in:
- European Journal of Immunology, 2019, v. 49, n. 11, p. 2083, doi. 10.1002/eji.201848039
- By:
- Publication type:
- Article